锁核酸SPC3649在HCV抗感染治疗中的研究进展
被引量：1
摘要
丙型肝炎病毒（HcV）是由约9．6kb个核苷酸组成的单股正链RNA病毒，属于黄病毒科丙型肝炎病毒属，被分为7个基因型及若干亚型。丙型肝炎是由HCV感染引起的常见血液传播型疾病，全球约有1．8亿人感染，引起慢性肝炎、肝硬化、肝癌。至今没有针对HCV的保护性疫苗，目前批准的标准治疗方式主要是聚乙二醇一干扰素（PEG—IFN）和利巴韦林（RBV）的联合疗法。
出处
《病毒学报》
CAS
CSCD
北大核心
2011年第6期614-618,共5页
Chinese Journal of Virology
基金
病毒基因工程重点实验室课题
国家传染病科技重大专项(2009ZX10004-705
-715)
参考文献36
-
1Simmonds P, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes [J]. Hepatology, 2005, 42:962-973.f.
-
2Moradpour D, Penin F, Rice C M . Replication of hepatitis C virus [J]. Nat Rev Microbiol, 2007, 5:453-463.
-
3Fried M, Hadziyannis S. Treatment of chronic hepatitis C infection with peginterferons plus ribavirin [J]. Semin Liver Dis, 2004, 24(Suppl 2): 47-54.
-
4Hoofnagle J H, Seer L B. Peginterferon and ribavirin for chronic hepatitis C [J]. N Engl J Med, 2006, 355: 2444-2451.
-
5Orito E, Mizoguchi N. Hepatitis-C virus serotype 2 response more favourably to interferone alpha therapy [J]. J Hepatol, 1994, 21:130-132.
-
6He Y, Duan W, Tan S L. Emerging host cell targets for hepatitis C therapy [J]. Drug Discov Today, 2007, 12: 209-217.
-
7Judith M Gottwein, Jens Bukh. Hepatitis C virus-host cell interactions uncovered [J]. Proc Natl Acad Sci USA, 2007, 104-13215-13216.
-
8Ambros V. The functions of animal microRNAs [J]. Nature, 2004, 431:350-355.
-
9Bartel D P. MicroRNAs : genomics, biogenesis, mecha nism, and function[J]. Cell, 2004, 116:281-297.
-
10Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse [J]. Curr Bio, 2002, 12(9):735-739.
二级参考文献14
-
1Moradpour D, Penin Fo, Rice CM. Replication of hepatitis C virus. Nat Rev Microbiol.2007; 5:453-463.
-
2McHutchison JG, Lawitz E J, Shiftman ML, et al Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. N Engl J Med 2009; 361:580-593.
-
3Jopling CL, Schutz S, Samow E Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 2008; 4:77-85.
-
4Jopling CL, Yi M, Lancaster AM, Lemon SM, Samow E Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309:1577-1581.
-
5Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327:198-201.
-
6Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115:787-798.
-
7Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP. Vertebrate microRNA genes. Science 2003; 299:1540.
-
8Chekulaeva M, Filipowicz W. Mechanisms of miRNA-mediated post-lranscriptional regulation in animal cells. Curr Opin Cell Biol.2009; 21:452-460.
-
9Gottwein E, Cullen BR. Viral and cellular microRNAs as determinants of viral pathogenesis and immtmity. Cell Host Microbe 2008; 3:375-387.
-
10Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3:87-98.
二级引证文献4
-
1范东伟,姚昌洋,姚廷敬.三阴性乳腺癌的研究进展[J].医学综述,2018,24(1):71-75. 被引量：16
-
2杨庆辉,李伟伟,王瑾,路平.肝内胆管癌上皮组织miR-215表达与病理特征的相关性[J].现代消化及介入诊疗,2019,24(5):529-532. 被引量：3
-
3李文娟,聂尚丹,亚白柳,王春梅.miR let-7f对流行性乙型脑炎病毒在神经元细胞中复制的调控作用[J].济宁医学院学报,2019,42(6):390-394. 被引量：2
-
4刘清高,陈文革.miR-30a-5p靶向SIRT1调控骨关节炎软骨细胞增殖和凋亡的研究[J].现代免疫学,2020,40(5):372-378. 被引量：1
-
1许琳,龙綮新.黄病毒的分子生物学研究进展[J].华南理工大学学报（自然科学版）,1996,24(S1):114-119.
-
2左氧氟沙星和环丙沙星与其它抗生素联用对铜绿假单胞菌和不动杆菌的抗菌活性[J].国外医药（抗生素分册）,2005,26(2):93-93.
-
3同颖娜,李丹.microRNA的液体芯片检测方法[J].分子诊断与治疗杂志,2011,3(3):200-202. 被引量：1
-
4余文辉,周大桥,周小梅,李伟雄,张春雷,冯玉丽,贺劲松,陈雪红,林卓玲.锁核酸捕获TaqMan探针实时聚合酶链反应构建及检测乙型肝炎病毒DNA[J].中华生物医学工程杂志,2011,17(3):239-243.
-
5严颖,国荣,麦丽,李展翼,朱建芸,林潮双,赵志新,张晓红.SOCS-3表达水平对CHC患者Peg-IFN/RBV疗效预测价值的探讨[J].中华实验和临床病毒学杂志,2015,29(3):245-247.
-
6童德妍,汪晓华,王缨,储以微,熊思东.SARS病毒:非典型肺炎相关病毒[J].生命的化学,2003,23(3):165-166. 被引量：3
-
7严延生,于恩庶.艾滋病疫苗的研究进展[J].中国人兽共患病杂志,2003,19(2):88-91. 被引量：3
-
8黄晓燕（摘）.Santaris展示新的LNA候选物[J].国外药讯,2008(12):23-23.
-
9唐盈,王燕菲.针对HBVS基因的反义锁核酸抗乙肝病毒表达的初探[J].江西医药,2006,41(4):205-208. 被引量：10
-
10杨波,卢学春.细胞因子诱导的杀伤细胞联合疗法预防淋巴瘤肝脏转移及复发取得显效[J].首都医药,2011,18(11):17-17.
